Data on ER and PR status were missing for 41% of DCIS cases (ER, n = 2546; PR, n = 2576), largely reflecting earlier periods of diagnoses when hormone receptor testing was not widely used. Here, NR4A1 is linked to ductal breast carcinoma in situ.